Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
July 25, 2018
Data from BioTime’s OpRegen® Program to Be Presented at AAO 2018
BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that its abstract “PI/IIa Study of Subretinally Transplanted Human Embryonic ...
July 25, 2018
Cormedix Inc. Announces Positive Results Of Its Neutrolin(R) Phase 3 Lock-It-100 Study Based On Recommendation By Independent Data Safety Monitoring Board
BERKELEY HEIGHTS, NJ / ACCESSWIRE / July 25, 2018 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products ...
July 25, 2018
RedHill Biopharma Initiates Co-Promotion of HIV/AIDS Anti-Diarrheal Drug Mytesi®
TEL-AVIV, Israel and RALEIGH, N.C., July 25, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical ...
July 25, 2018
Albireo Appoints Patrick Horn MD, PhD as Chief Medical Officer
BOSTON, July 25, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
July 25, 2018
Theravance Biopharma to Report Second Quarter 2018 Financial Results on August 1
DUBLIN, July 25, 2018 /PRNewswire/ -- Theravance Biopharma, Inc. (TBPH) ("Theravance Biopharma" or the "Company") today announced that it will release financial results for the ...
July 25, 2018
PolarityTE, Inc. Provides Commercial Update
SALT LAKE CITY, July 25, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (COOL), a commercial-stage biotechnology and regenerative biomaterials company, today announced an update on the ...
July 24, 2018
Celyad Announces FDA Acceptance of IND Application for CYAD-101, a First-in-Class Non-Gene Edited Allogeneic CAR-T Candidate
MONT-SAINT-GUIBERT, Belgium, July 24, 2018 (GLOBE NEWSWIRE) --  Celyad (Euronext Brussels:CYAD) (Euronext Paris:CYAD) (CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell therapies, ...
July 24, 2018
Sensorion Initiates Safety Study of Seliforant Versus Meclizine In Evoked Vestibular Imbalance
MONTPELLIER, France, July 24, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN), a biotech company specializing in the treatment of inner ear diseases, today announced ...
July 24, 2018
EDAP TMS SA to Announce Second Quarter 2018 Financial Results on Thursday, August 30
LYON, France, July 24, 2018 - EDAP TMS SA (EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results ...
July 24, 2018
Aptose To Release Second Quarter Ended June 30, 2018 Financial Results and Hold Conference Call on August 7, 2018
SAN DIEGO and TORONTO, July 24, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (APTO) (APS.TO), a clinical-stage company developing highly differentiated therapeutics targeting the underlying ...
July 24, 2018
Arrowhead Pharmaceuticals to Webcast Fiscal 2018 Third Quarter Results
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (ARWR) today announced that it will host a webcast and conference call on August 7, 2018, at 4:30 p.m. EDT ...
July 24, 2018
Allakos Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
SAN CARLOS, Calif., July 24, 2018 (GLOBE NEWSWIRE) -- Allakos Inc. (ALLK), a clinical stage biotechnology company focused on the development of antibodies for the ...
July 24, 2018
HTG Molecular Diagnostics to Announce Second Quarter and Six Months Ended June 30, 2018 Financial Results and Host Conference Call on Tuesday, August 7
TUCSON, Ariz., July 24, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today ...
July 24, 2018
scPharmaceuticals Announces Appointment of Two New Directors
BURLINGTON, Mass., July 24, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to ...
July 24, 2018
Achaogen to Host Conference Call and Webcast of Second Quarter 2018 Financial Results on August 6, 2018
SOUTH SAN FRANCISCO, Calif., July 24, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a biopharmaceutical company developing and commercializing innovative antibacterial agents to address multi-drug ...
July 24, 2018
RedHill Biopharma Enrolls 400th Patient in Confirmatory Phase III Study with TALICIA® for H. pylori Infection
TEL-AVIV, Israel and RALEIGH, N.C., July 24, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical ...
July 23, 2018
Reata Announces Positive Phase 2 Data for Bardoxolone Methyl in CKD Caused by Alport Syndrome and Autosomal Dominant Polycystic Kidney Disease
IRVING, Texas, July 23, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (RETA), a clinical-stage biopharmaceutical company, today announced results from two Phase 2 studies of ...
July 23, 2018
Arcturus Therapeutics Achieves Program Milestones and Refines Agreement with Cystic Fibrosis Foundation Therapeutics
SAN DIEGO, July 23, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (ARCT), a leading RNA medicines company, today announced the achievement of key milestones as ...
July 23, 2018
BioTime to Announce Second Quarter 2018 Results on August 2, 2018
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that it will release second quarter 2018 financial ...
July 23, 2018
RedHill Biopharma Announces Uplisting to Nasdaq Global Market
TEL-AVIV, Israel and RALEIGH, N.C., July 23, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical ...
Page 47 of 138